Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Vaccinex
(NASDAQ:VCNX)
Intraday
$4.64
-0.12
[-2.52%]
After-Hours
$4.64
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$4.64
-0.12
[-2.52%]
At close: Apr 17
$4.64
0
[0.00%]
After Hours: 7:36PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Vaccinex Stock (NASDAQ:VCNX)
Vaccinex Stock (NASDAQ: VCNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 02, 2024
Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoY
Benzinga Newsdesk
-
Apr 2, 2024, 10:59PM
Vaccinex Expects Topline Data For Phase 1/2a Randomized SIGNAL-AD Study Of Pepinemab For Alzheimer's Disease In Q3 2024
Benzinga Newsdesk
-
Apr 2, 2024, 8:45AM
Vaccinex FY23 EPS $(43.68) Up From $(98.05) YoY, Revenue $570K Up From $275K YoY
Benzinga Newsdesk
-
Apr 2, 2024, 8:44AM
Wednesday, March 27, 2024
Vaccinex, Inc. Announces $1.5M Registered Direct Offering And Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Benzinga Newsdesk
-
Mar 27, 2024, 8:31AM
Wednesday, February 21, 2024
Vaccinex Announces It Has Entered Into Eight New Antibody Discovery Agreements Integrating Use Of Its Proprietary ActivMAb Platform To Select Antibodies Against Difficult-To-Drug Transmembrane Protein Targets
Benzinga Newsdesk
-
Feb 21, 2024, 8:21AM
Tuesday, February 20, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Feb 20, 2024, 8:55AM
Friday, February 16, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Feb 16, 2024, 7:50PM
Thursday, February 15, 2024
Why Vaccinex (VCNX) Stock Is Trading Lower
Henry Khederian
-
Feb 15, 2024, 9:31AM
Vaccinex, Inc. Announces 1-For-14 Reverse Stock Split
Benzinga Newsdesk
-
Feb 15, 2024, 8:06AM
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 14, 2024, 4:31PM
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 9, 2024, 4:31PM
Wednesday, February 07, 2024
Why Vaccinex (VCNX) Stock Is Popping Off
Henry Khederian
-
Feb 7, 2024, 11:09AM
Vaccinex Announces Pricing Of $3.7M Private Placement For The Sale Of An Aggregate 3,838,544 Shares Of Common Stock
Benzinga Newsdesk
-
Feb 7, 2024, 8:08AM
Monday, December 04, 2023
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
Benzinga Newsdesk
-
Dec 4, 2023, 8:09AM
Monday, November 13, 2023
Vaccinex Q3 EPS $(1.09) Up From $(1.65) YoY
Benzinga Newsdesk
-
Nov 13, 2023, 8:22AM
Tuesday, October 31, 2023
Vaccinex Reports Clinical Benefit In Interim Analyses From Two Phase 2 Studies Of Pepinemab Combination Treatment At Society For Immunotherapy Of Cancer's Annual Meeting
Benzinga Newsdesk
-
Oct 31, 2023, 9:13AM
Thursday, October 26, 2023
Director at Vaccinex Exercises Options Worth $11K
Benzinga Insights
-
Oct 26, 2023, 11:00AM
Vaccinex Reports Effect Of Pepinemab Treatment On New Biomarker Of Brain Inflammation In Neurodegenerative Diseases
Benzinga Newsdesk
-
Oct 26, 2023, 9:31AM
Friday, October 13, 2023
On Oct 10, Vaccinex ot Letter From Nasdaq Listing Staff Stating That Co Has Not Regained Compliance With Minimum Bid Price Standard
Benzinga Newsdesk
-
Oct 13, 2023, 5:03PM
Wednesday, October 11, 2023
Vaccinex 13G Filing Shows Orin Hirschman Holds 9.9% Passive Stake In Co As Of September 28
Benzinga Newsdesk
-
Oct 11, 2023, 12:36PM
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Oct 9, 2023, 5:31PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Oct 9, 2023, 1:31PM
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 9, 2023, 1:30PM
Friday, October 06, 2023
Gold Moves Higher; OMNIQ Shares Plunge
Lisa Levin
-
Oct 6, 2023, 2:31PM
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 6, 2023, 1:59PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Oct 6, 2023, 1:31PM
Vaccinex shares are trading higher after two insider buys were reported after the close on Thursday.
Bill Haddad
-
Oct 6, 2023, 11:19AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Oct 6, 2023, 9:06AM
Market-Moving News for October 6th
Benzinga Newsdesk
-
Oct 6, 2023, 8:39AM
Why Pioneer Natural Resources Shares Are Bouncing By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 6, 2023, 8:26AM
Vaccinex Shares Up 43% Premarket. Two Large Insider Buys Were Reported After The Close On Thursday
Charles Gross
-
Oct 6, 2023, 4:39AM
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Oct 5, 2023, 5:32PM
Friday, September 29, 2023
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 29, 2023, 2:09PM
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Sep 29, 2023, 1:31PM
Vaccinex shares are trading lower after the company announced the pricing of a $9.6 million public offering of 9.6 million shares and warrants at $1 per share.
Benzinga Newsdesk
-
Sep 29, 2023, 10:39AM
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
Lisa Levin
-
Sep 29, 2023, 10:16AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Sep 29, 2023, 9:05AM
Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Sep 29, 2023, 8:15AM
Vaccinex Prices $9.6M Public Offering Of 9.6M Common Shares And Warrants At $1/Share
Benzinga Newsdesk
-
Sep 29, 2023, 3:07AM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Vaccinex shares are trading higher after the company announced its next generation ActivMAb technology was published in mAbs and validated in an OmniAb proof-of-concept collaboration.
Benzinga Newsdesk
-
Sep 28, 2023, 11:27AM
Vaccinex's Next Generation ActivMAb Technology Published In mAbs, A Leading Biotech Journal, And Validated In OmniAb Proof-Of-Concept Collaboration
Benzinga Newsdesk
-
Sep 28, 2023, 8:10AM
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Vaccinex Recent Insider Activity
Benzinga Insights
-
Sep 26, 2023, 11:03AM
Vaccinex Reports Groundbreaking Findings At Medical Conferences Supporting Development Of Pepinemab For The Treatment Of Neurodegenerative Diseases And Cancer
Benzinga Newsdesk
-
Sep 26, 2023, 8:14AM
Monday, September 25, 2023
Thor Industries, AutoNation And 3 Stocks To Watch Heading Into Monday
Lisa Levin
-
Sep 25, 2023, 4:41AM
Friday, September 22, 2023
Vaccinex, Inc. Announces 1-For-15 Reverse Stock Split
Benzinga Newsdesk
-
Sep 22, 2023, 4:33PM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch